oncology pharmacy navigator: a novel model for medication

33
Oncology Pharmacy Navigator: A Novel Model for Medication Management Kelly Rice, Pharm.D. Oncology Pharmacy Navigator Legacy Cancer Institute Portland, Oregon

Upload: others

Post on 16-Oct-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Oncology Pharmacy Navigator: A Novel Model for Medication

Oncology Pharmacy Navigator:A Novel Model for

Medication Management

Kelly Rice, Pharm.D.

Oncology Pharmacy Navigator

Legacy Cancer Institute

Portland, Oregon

Page 2: Oncology Pharmacy Navigator: A Novel Model for Medication

Objectives

Understand the role of an oncology pharmacynavigator in a system cancer program

Name two cost saving programs that support theexpense of an oncology pharmacy navigatorposition

Give examples of reasons cancer patients usemarijuana and cite one barrier to access.

No disclosures

May 1, 2017 2

Page 3: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 3

Page 4: Oncology Pharmacy Navigator: A Novel Model for Medication

Identification of Need The vast majority of anticancer treatment is given

outpatient, but Legacy Health had no oncologypharmacist dedicated to its outpatient clients.

Upwards of 50% of patients do not take their medicationscorrectly

Med discrepencies, adverse events, and non-complianceare leading causes of 30 day hospital readmissions

Cancer patients are highly satisfied when able to consultwith pharmacist.

Consultation allows patients and providers to focus onmanagement of their cancer

Novel model in the community, state, and nation. “BestPractice Model” according to ACS surrveyors.

May 1, 2017 4

Page 5: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 5

Page 6: Oncology Pharmacy Navigator: A Novel Model for Medication

Timeline

February 2014: Development of proposal for new position,research done

April 2014: proposal presented to Legacy Cancer Institute (LCI)medical and administrative directors. Endorsed

November 2014: LGS Foundation Grant Requested for one yearpilot position. February 2015: LCI granted funds for 0.4FTEposition for one year

August 2015: First quarter pilot results presented to LCIadministration, increased to 0.5 FTE position

April 2016: FTE position budgeted into LCI annual costs.

May 1, 2017 6

Page 7: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 7

Launch Office in LCI Healing Center, Bldg 3, lower level

Very steep learning curve for outpatient EPIC as wellas launching a new position (referral took 3 months!)

EPIC outpatient training (4 hours)

> Med Rec over the phone (must use orders onlyencounter) and for office visits

> Creating current med lists and “Frig Lists” forpatients over the phone and for office visits

Pts can access via My Health (preferred emailformat)

Page 8: Oncology Pharmacy Navigator: A Novel Model for Medication

Your pharmacy navigator will help you:

Understand your medications

Provide a current and accurate medication list

Understand the side effects of your medications & helpmanage the symptoms

Make it easier to take your medications correctly throughcoaching, medicine schedules, and pillboxes

Address medication related symptoms quickly

Explore financial concerns related to your medicine

May 1, 2017 8

Page 9: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 9

Page 10: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 10

Page 11: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 11

Fridge Med List:

can be accessed from AVS or from

an outpatient visit navigator

Page 12: Oncology Pharmacy Navigator: A Novel Model for Medication

Ambulatory Flowsheet Changes

May 1, 2017 12

Needs Assessment: add Concerns re: Medication Adherenceyes/noAdd new section entitled “Medication Concerns”Medication reconciliation completed in EPIC: yes/noMed Rec # of meds on med list: enter a #Med Rec changes made: enter a #Med rec additions made: enter a #Med rec deletions made: enter a #Provided with epic med list: yes/noProvided with medication schedule: yes/noAssist patient with pill box: yes/noMed teaching provided: purpose of meds, timing of meds, and/orside effect managementHealth Literacy concerns: yes/noMedication adherence concerns: yes/noPatient on high risk medication (yes/no):If yes, choose one or several of these: anticoagulants, anticancerhormonal therapy, chronic opioids, oral chemotherapy, insulin,significant drug interaction potentialFinancial/Insurance concerns: yes/noAssist patient with smartphone app for adherence: yes/no

Add

Page 13: Oncology Pharmacy Navigator: A Novel Model for Medication

Additional Services Provided:

Chemo teaching for all LMG Gyn Oncchemo patients at LGS

6sw Bowel Protocol Quality Tracking

Cancer support group presentations

Attendance at two weekly huddles andGYN Cancer Conferences weekly

May 1, 2017 13

Page 14: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 14

Page 15: Oncology Pharmacy Navigator: A Novel Model for Medication

Estimated Cost Savings

May 1, 2017 15

Annual Savings FY 2016: $208,242Annual Savings FY 2017: $205,380

Examples of cost savings:

$5000 Enroll oral chemo patient on foundation grant support$7800 Enroll patient in free Humira program$60,375 Enroll several patients on Lynparza Rx program$15,000 change from oral aprepitant to IV form on formulary$1300 Revenue from LGS Apothecary selling supplements$800 copay assistance for RadOnc pts “Magic Mouthwash”

Page 16: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 16

Page 17: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 17

Volumes & referrals

Page 18: Oncology Pharmacy Navigator: A Novel Model for Medication

Medication Reconciliation

Over 110 patients had comprehensive medicationreconciliation completed in Legacy EPIC system:

Only 2% had entirely correct med lists

May 1, 2017 18

Average Low High

Meds on EPIC List 12 1 42

Meds Missing 1.8 0 10

Meds no longer Active 2.4 0 12

Meds needing Change 1.4 0 5

Page 19: Oncology Pharmacy Navigator: A Novel Model for Medication

Quality metrics

May 1, 2017 19

Page 20: Oncology Pharmacy Navigator: A Novel Model for Medication

Future Plans

Expand services to other Legacy sites viaphone consult

Conduct patient and provider satisfactionsurveys

Receive foundation grant funds to pay forsupplements for some chemo patients

Identify additional Pharma support programs

Develop an Oral Chemotherapy Program at LCI

May 1, 2017 20

Page 21: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 21

Page 22: Oncology Pharmacy Navigator: A Novel Model for Medication

Oral Chemotherapy Program

Patients need financial support in obtaining their medicines

They also need experts to manage their medications.

Team members will assist the provider in:

> patient selection

> perform insurance authorization, investigate and appeal all

denied claims

> improve access to medications

> provide ongoing monitoring for adherence and side effects

Provide patient specific medication therapy management,

ensure that patients understand their medicines

May 1, 2017 22

Page 23: Oncology Pharmacy Navigator: A Novel Model for Medication

Medical Marijuana and Cancer Patients

May 1, 2017 23

Page 24: Oncology Pharmacy Navigator: A Novel Model for Medication

What do cancer patients ask for? Two main components of cannabis: THC and CBD

Most dispensaries steer cancer patients towards productshigh in CBD.

Symptom relief

Nausea sleep

Appetite stimulation depression

Pain menopausal sx

Anxiety

Cure for their cancer:

> Primarily “RSO” = Rick Simpson Oil

May 1, 2017 24

Page 25: Oncology Pharmacy Navigator: A Novel Model for Medication

Rick Simpson Oil (RSO)

85-88% THC

Patients often referred to the “SimpsonWebsite” = www.siskiyousungrown.com

Comes only as a very concentrated solutionin a syringe

Only available to MM card holders,not recreational users

Cost $30-50 per syringe, titrate up to onesyringe/day . Discounts available, butstill costs $700-$1000/month

May 1, 2017 25

Page 26: Oncology Pharmacy Navigator: A Novel Model for Medication

May 1, 2017 26

Page 27: Oncology Pharmacy Navigator: A Novel Model for Medication

What types of cannabis products are available? Bud/flower: for smoking or edibles

> % THC & CBD shown

Tinctures/concentrates in dropper bottles

> Mg THC & CBD shown

Vape cartridges/syringes

“shatter/sap” strong hashish concentrate

Gummies, lozenges, candy

Topical salves, bath salts, lip balm

Plants

Sodas, drinks

Other edibles = short shelf life

May 1, 2017 27

Page 29: Oncology Pharmacy Navigator: A Novel Model for Medication

OR Medical Marijuana Program (OMPP)

Approved conditions:

> Cancer

> Glaucoma

> HIV/AIDS

> degenerative neurological condition

> PTSD

> Cachexia

> severe pain or nausea

> Seizures

> persistent muscle spasms (ie MS)

May 1, 2017 29

Page 30: Oncology Pharmacy Navigator: A Novel Model for Medication

Why get a medical marijuana card?

Card requires an MD or DO statement and costs$200 (reduced fees available)

Cost savings (avoids 25% Oregon sales tax)

“higher quality product”

Can grow more plants

Can buy more at a time and possess more

Access to some products not available for rec users

Need to use OMMP licensed dispensaries

May 1, 2017 30

Page 31: Oncology Pharmacy Navigator: A Novel Model for Medication

Common Questions about Cannabis

Can I recommend it to my patients?

How to choose a dispensary?

Is cannabis organic? Are there excipients?

Does topical cannabis cause blood levels?

Is there research?www.researchcannabis.org

www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

J Natl Compr Canc Netw 2016;14(7) 915-922.Cannabinoids for Sx Mgmt and Cancer Therapy: The Evidence

May 1, 2017 31

Page 32: Oncology Pharmacy Navigator: A Novel Model for Medication

Summary A need was identified, a position created and successfully

funded for a pilot study and beyond

98% of medicine lists are inaccurate, and med rec done asoutpatient is an important role of the OPN

Financial savings projected at over $200K annually.

Many cancer patients are interested in medical marijuana.We should be knowledgeable to answer their questionsand outline the pros, cons, and logistics of accessingcannabis products.

The OPN is an innovative role which distinguishes ourcancer program, assists in accreditation, and mostimportantly benefits the cancer patients we serve.

May 1, 2017 32

Page 33: Oncology Pharmacy Navigator: A Novel Model for Medication

Thank you! Questions????

[email protected] 503.413.6590